RECOMMENDED APPOINTMENT
Book a Standard consultation for routine cervical screening. Choose Long if you have symptoms, a complex screening history or other concerns to discuss. If you prefer a nurse collection, please contact reception to arrange it.
CERVICAL HEALTH
Our practitioners and nurses can assist with routine cervical screening and explain the collection method that is appropriate for you. The Cervical Screening Test (CST) replaced the traditional Pap smear in Australia and tests for human papillomavirus (HPV), the virus responsible for almost all cervical cancers.
You can discuss your screening history, any reminders you have received and whether you would prefer a clinician-collected sample or, where suitable, self-collection. Every sample is sent to a pathology laboratory for analysis, and your practitioner will advise you about any necessary follow-up.
A letter from the National Cancer Screening Register (NCSR) generally means you are due or overdue for screening or follow-up. Bring it to your consultation if you have it.
Not sure when you last screened? Call the NCSR on 1800 627 701 or ask your practitioner to review your available screening history.
Where clinically appropriate, cervical screening can be performed during your booked GP consultation.
No additional cervical collection fee is charged by DC Medical Centre when the sample is collected by your practitioner as part of your consultation. The usual consultation fee and any applicable pathology charges remain separate.
You may request a cervical screening appointment with our nurse. Please contact reception to organise a suitable time and confirm the booking requirements.
$50 nurse collection fee applies. This is a DC Medical Centre fee for the nurse appointment; separate pathology billing may apply if a test is not Medicare eligible.
Your GP or nurse uses a speculum to view the cervix and a small soft brush to collect the sample. This option allows assessment of the cervix and collection of cervical cells when required.
It is particularly important when symptoms or a clinical pathway require a cervical examination and a combined HPV and cytology test (co-test).
If you are eligible, your practitioner can provide a swab and instructions. You privately collect a vaginal sample, usually in the practice bathroom. You do not need to insert the swab into your cervix.
Self-collection is similarly accurate for detecting HPV in eligible routine screening participants, but it is not appropriate when a co-test is required or when certain symptoms need examination.
You can book a consultation with your GP or nurse for assessment regardless of when your last screening test was. Your clinician determines whether a cervical sample, diagnostic investigation or another assessment is appropriate. The eligibility rules below apply to Medicare payment for the pathology laboratory's processing of the test. If the specific pathology item requirements are not met, the laboratory may charge you, or it may be unable to process a routine screening request without an appropriate indication. The practice consultation fee and optional $50 nurse collection fee are separate.
| Situation | Laboratory Medicare eligibility | Usual test / MBS pathway |
|---|---|---|
| Routine screening, no symptoms | At least 24 years and 9 months old, usually with a cervix and a history of sexual contact, and no routine HPV screening test claimed in the previous 57 months. Routine invitations generally start around age 25 and the recommended interval is five years. Vaccinated patients still screen. | HPV test: 73070 clinician-collected cervical specimen, or 73071 self-collected vaginal specimen. |
| Routine test earlier than 57 months | A standard routine HPV test is not generally Medicare-claimable solely because the patient wants an early repeat. Check whether a distinct clinical follow-up or diagnostic indication applies before collection. | Usually not 73070/73071; another item may apply only when its separate clinical criteria are met. |
| Under 25 with early sexual debut | Routine screening is not normally recommended under 25. A single HPV test at ages 20–24 may be considered case-by-case for someone who first had sexual activity before age 14 and was not HPV-vaccinated before that contact. | Special-population HPV testing under 73072 where the guideline criteria are met; early sexual activity alone is not sufficient. |
| Symptoms suggesting cervical disease | Symptoms such as bleeding after sex, unexplained intermenstrual or postmenopausal bleeding require medical assessment and may justify diagnostic HPV + liquid-based cytology (co-test), regardless of routine screening timing or age, when clinically indicated. | Diagnostic 73072 with cytology under 73076 where applicable. Clinician-collected cervical sample required for a complete co-test. |
| Immune deficiency or follow-up of abnormal results | Separate pathways can cover 3-yearly HPV screening in immune-deficient patients, approximately 12-month follow-up of certain HPV results, and tests after treatment of high-grade abnormalities. The exact interval is determined by the national clinical management pathway. | 73072 when the specific clinical indication is documented; cytology may also be required. |
| After total hysterectomy or other special history | Eligibility depends on why the hysterectomy occurred and any history of cervical precancer, cancer or abnormal results. Some patients need vaginal vault surveillance; others do not require ongoing testing. | Specialised testing such as 73074 where criteria apply; clinician determines the appropriate sample and request. |
| Unsatisfactory prior laboratory sample | Recollection may be Medicare-claimable where the earlier test was unsatisfactory and the relevant repeat-item conditions are met. | Repeat HPV testing under 73075, as applicable. |
The treating practitioner must specify the reason for testing on the pathology request. The laboratory determines whether it can claim the relevant MBS item. See the official MBS cervical testing notes and National Cervical Screening Program.
Australia recommends routine screening for most people aged 25–74 who have a cervix and have ever had sexual contact, generally every five years following a normal result. For pathology Medicare billing, routine testing can begin at 24 years and 9 months, and the routine item is claimable only once in a 57-month period.
People who have not screened previously, are aged 75 or over, are immunodeficient or have a history of abnormal results may need an individualised plan. Cervical screening after hysterectomy depends on the reason for surgery and previous results.
If you have had sexual contact before age 14 and were not vaccinated against HPV before that contact, discuss the specific one-off testing option at ages 20–24 with your practitioner; it is not automatic eligibility for early routine screening.
Unexplained bleeding after sex, between periods or after menopause, or persistent unusual discharge or pain, warrants clinical assessment even if a routine screening test is not yet due.
Depending on the clinical findings, a clinician-collected HPV/cytology co-test and other investigations may be needed. Symptomatic patients are not automatically entitled to annual testing; the applicable pathology billing criteria depend on the diagnostic indication.
Your practitioner checks when you last screened, prior results, symptoms and the most suitable collection option.
A practitioner or nurse collects the sample, or you self-collect in private if eligible and preferred.
We send the sample to pathology. Your practitioner reviews the result and advises you if further testing or follow-up is needed.
Let your practitioner know if you have vaginal bleeding, discharge, are pregnant, have previously had cervical treatment or have a history of abnormal tests.
Where possible, schedule routine clinician collection when you are not having heavy menstrual bleeding. Your practice team can advise about timing; do not delay assessment of concerning symptoms.
Medicare pathology eligibility is separate from your eligibility to see a practitioner. Your GP can examine you and request clinically appropriate testing at any time. The laboratory can claim Medicare only if the specific pathology item criteria are met (for example, routine HPV screening from 24 years and 9 months and no routine claim in the previous 57 months, or a documented diagnostic/follow-up indication). Outside these criteria, pathology charges may apply.
The $50 nurse collection fee is separate from the laboratory charge. GP collection has no additional practice collection fee beyond your consultation. The pathology laboratory, not the practice, determines and issues any pathology invoice. Ask about potential pathology charges before testing if you are outside the routine or clinical criteria.
The National Cancer Screening Register can provide information about your screening status and reminders. Call 1800 627 701 or visit ncsr.gov.au. If you have symptoms, book a clinical assessment even if the register says your routine screening is not yet due.
The Cervical Screening Test (CST) replaced the traditional Pap smear in Australia in 2017. Routine CST primarily looks for HPV, which can cause cervical cell changes. Further cell testing is performed when indicated.
For most eligible people aged 25–74, a routine HPV screening test is recommended every five years following a normal result. Your clinician may recommend a different follow-up interval after an abnormal result, treatment or for other clinical reasons.
A letter may indicate you are due, overdue or require follow-up. Arrange a Standard consultation for routine screening or contact reception if you prefer nurse collection. Bring the letter if available.
Yes. Your GP or treating practitioner can collect your sample during a suitable consultation. DC Medical Centre does not charge an additional cervical collection fee when the test is performed during that consultation; usual consultation and any applicable pathology fees remain separate.
Yes. Please contact reception to arrange a nurse appointment. DC Medical Centre charges a $50 nurse collection fee. Pathology fees may be charged separately when Medicare eligibility conditions are not met.
If you are eligible for routine HPV screening and do not need a co-test, you can choose self-collection. Your practitioner provides instructions and a swab, and you take a vaginal sample privately. It is not a swab of the cervix.
For detecting HPV in eligible routine screening patients, self-collection is similarly accurate. It cannot provide cervical cell cytology, so some HPV results or clinical circumstances require further clinician-collected testing.
Usually not when symptoms suggest cervical disease and a diagnostic co-test or examination is indicated. Tell your clinician about unexplained bleeding, bleeding after sex or persistent unusual discharge so the appropriate investigations can be arranged.
Symptoms do not create a routine entitlement to annual HPV screening. Your clinician will assess the symptoms and determine whether diagnostic co-testing, examination, imaging or specialist referral is required.
Routine screening is recommended from age 25, but Medicare routine pathology items can apply from 24 years and 9 months. A one-off HPV test at ages 20–24 may be considered for people who first had sexual contact before 14 and were not HPV-vaccinated before that contact. Symptoms and certain follow-up indications have different criteria. Your GP can assess you regardless of these pathology billing rules.
Call the National Cancer Screening Register on 1800 627 701 or ask your healthcare provider to review available screening information. The register can also assist with screening reminders.
Yes. HPV vaccination greatly reduces risk but does not protect against every cancer-causing HPV type. Eligible people with a cervix still need regular screening.
If you are due or overdue, cervical screening can usually be performed safely during pregnancy. Tell your practitioner you are pregnant so the collection method and any follow-up can be selected appropriately.
Your practitioner will follow the national clinical management pathway. Depending on the HPV type, your history and the result, you may need cervical cell testing, repeat HPV testing or referral for colposcopy. A positive HPV result does not mean you have cervical cancer.
Timing depends on the pathology laboratory and any additional analysis required. DC Medical Centre sends your sample to pathology, and your practitioner reviews the result and advises you of any follow-up required. Contact reception if you have not received an expected result.
The laboratory can bill Medicare only where the relevant pathology item criteria are met. For routine asymptomatic HPV testing, this generally means age at least 24 years and 9 months and no routine HPV test claimed in the previous 57 months. Other items can cover specific symptoms, higher-risk patients and follow-up. If the laboratory cannot claim an item, it may issue a private invoice. Your consultation fee and $50 nurse fee (where applicable) are separate.
Yes. Your GP can assess symptoms, perform a clinically appropriate examination and decide whether testing is necessary. The eligibility thresholds determine whether the pathology laboratory can bill Medicare for the particular test; they do not prevent you from booking a practitioner consultation.
A normal result generally leads to a recommended five-year screening interval, but the routine MBS pathology items 73070 and 73071 use a 57-month claiming interval (four years and nine months). Different intervals may apply to diagnostic testing and abnormal-result follow-up.
Screening eligibility and follow-up depend on your age, previous results, symptoms and clinical circumstances. A routine cervical screening test does not replace assessment of unexplained bleeding, pain or discharge. Your practitioner will advise on the most appropriate examination or investigations.
Book a Standard appointment for routine cervical screening or a Long appointment for multiple concerns or symptoms. To arrange a nurse collection ($50), please contact reception directly.
